{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:18:38Z","timestamp":1788394718356,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterised by progressive muscle weakness and ultimately death from respiratory failure. Heterogeneity in disease trajectories and outcomes among patients with ALS (pwALS) is influenced by healthcare access, rehabilitation, and palliative care, but real-world data on demographic and clinical characteristics remain scarce in many countries, including Austria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterise the demographic, clinical, and genetic landscape of pwALS in Austria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective cohort study, we included pwALS diagnosed according to the Gold Coast criteria and treated at two large tertiary referral centres. Demographic, clinical, and genetic data were extracted from the local ALS registries, and survival was determined via linkage with\n                      <jats:italic>Statistik Austria<\/jats:italic>\n                      , censored in December 2023.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 341 patients with motor neuron disease were included (44.9% female), of whom 5% were diagnosed with primary lateral sclerosis and 2.9% with progressive muscular atrophy. Among pwALS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009314), spinal onset was most common (67.2%), followed by bulbar onset (29.6%) and respiratory onset (2.5%). Median survival from symptom onset was 36.0\u00a0months (IQR 20.0\u201374.0), with age at onset (HR 1.04, 95% CI 1.02\u20131.05;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), diagnostic delay (HR 0.97, 95% CI 0.96\u20130.98;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), and PEG tube placement (HR 0.72, 95% CI 0.50\u20131.00;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0478) as the only independent predictors of survival. (Likely) pathogenic variants were identified in 5.5% of patients, including two in\n                      <jats:italic>SOD1<\/jats:italic>\n                      and one each in\n                      <jats:italic>C9orf72, OPTN<\/jats:italic>\n                      ,\n                      <jats:italic>TARDBP,<\/jats:italic>\n                      and\n                      <jats:italic>FUS<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides the first comprehensive description of the demographic, clinical, and genetic characteristics of pwALS in Austria, offering valuable real-world insight into disease presentation and genetic diversity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13614-y","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:45:57Z","timestamp":1768013157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Demographic, clinical and genetic characteristics of patients with amyotrophic lateral sclerosis from two specialised centres in Austria"],"prefix":"10.1007","volume":"273","author":[{"given":"Omar","family":"Keritam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Elisabeth","family":"Kleinveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Mayerhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Sener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Pugna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Gebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Fedak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Antoniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Zulehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang N.","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-7261","authenticated-orcid":false,"given":"Hakan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"5","key":"13614_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chio A, Savelieff MG, Kiernan MC et al (2022) Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol 21(5):480\u2013493. https:\/\/doi.org\/10.1016\/S1474-4422(21)00465-8","journal-title":"Lancet Neurol"},{"issue":"5","key":"13614_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1212\/01.wnl.0000200962.94777.71","volume":"66","author":"PH Gordon","year":"2006","unstructured":"Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H et al (2006) The natural history of primary lateral sclerosis. Neurology 66(5):647\u2013653. https:\/\/doi.org\/10.1212\/01.wnl.0000200962.94777.71","journal-title":"Neurology"},{"issue":"20","key":"13614_CR3","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1212\/WNL.0b013e3181c1dea3","volume":"73","author":"WK Kim","year":"2009","unstructured":"Kim WK, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP et al (2009) Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 73(20):1686\u20131692. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c1dea3","journal-title":"Neurology"},{"issue":"8","key":"13614_CR4","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131(8):1975\u20131978. https:\/\/doi.org\/10.1016\/j.clinph.2020.04.005","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"13614_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/jnnp-2019-322541","volume":"91","author":"MR Turner","year":"2020","unstructured":"Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC et al (2020) Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry 91(4):373\u2013377. https:\/\/doi.org\/10.1136\/jnnp-2019-322541","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"13614_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ana.26045","volume":"89","author":"A Hannaford","year":"2021","unstructured":"Hannaford A, Pavey N, van den Bos M, Geevasinga N, Menon P, Shefner JM et al (2021) Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis. Ann Neurol 89(5):979\u2013986. https:\/\/doi.org\/10.1002\/ana.26045","journal-title":"Ann Neurol"},{"issue":"9","key":"13614_CR7","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456\u20132477. https:\/\/doi.org\/10.1093\/brain\/awr179","journal-title":"Brain"},{"issue":"3-4","key":"13614_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J et al (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18(3\u20134):153\u2013174. https:\/\/doi.org\/10.1080\/21678421.2016.1267768","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"13614_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66(2):265\u2013267. https:\/\/doi.org\/10.1212\/01.wnl.0000194316.91908.8a","journal-title":"Neurology"},{"issue":"1","key":"13614_CR10","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","volume":"95","author":"M Benatar","year":"2020","unstructured":"Benatar M, Zhang L, Wang L, Granit V, Statland J, Barohn R et al (2020) Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95(1):e59\u2013e69. https:\/\/doi.org\/10.1212\/WNL.0000000000009559","journal-title":"Neurology"},{"key":"13614_CR11","doi-asserted-by":"publisher","first-page":"753242","DOI":"10.3389\/fnagi.2021.753242","volume":"13","author":"V Vacchiano","year":"2021","unstructured":"Vacchiano V, Mastrangelo A, Zenesini C, Masullo M, Quadalti C, Avoni P et al (2021) Plasma and CSF neurofilament light chain in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Front Aging Neurosci 13:753242. https:\/\/doi.org\/10.3389\/fnagi.2021.753242","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"13614_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","volume":"265","author":"D Rossi","year":"2018","unstructured":"Rossi D, Volanti P, Brambilla L, Colletti T, Spataro R, La Bella V (2018) CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. J Neurol 265(3):510\u2013521. https:\/\/doi.org\/10.1007\/s00415-017-8730-6","journal-title":"J Neurol"},{"issue":"6","key":"13614_CR13","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/ene.15773","volume":"30","author":"T Meyer","year":"2023","unstructured":"Meyer T, Salkic E, Grehl T, Weyen U, Kettemann D, Weydt P et al (2023) Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis-a cross-sectional multicenter study. Eur J Neurol 30(6):1600\u20131610. https:\/\/doi.org\/10.1111\/ene.15773","journal-title":"Eur J Neurol"},{"issue":"5","key":"13614_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"6","key":"13614_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00839964","volume":"240","author":"AM Chancellor","year":"1993","unstructured":"Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP (1993) The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 240(6):339\u2013346. https:\/\/doi.org\/10.1007\/BF00839964","journal-title":"J Neurol"},{"issue":"8","key":"13614_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archneur.57.8.1171","volume":"57","author":"BJ Traynor","year":"2000","unstructured":"Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM (2000) Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 57(8):1171\u20131176. https:\/\/doi.org\/10.1001\/archneur.57.8.1171","journal-title":"Arch Neurol"},{"issue":"1","key":"13614_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/wnl.59.1.99","volume":"59","author":"A Chio","year":"2002","unstructured":"Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT et al (2002) Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 59(1):99\u2013103. https:\/\/doi.org\/10.1212\/wnl.59.1.99","journal-title":"Neurology"},{"issue":"5","key":"13614_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1212\/01.wnl.0000049472.47709.3b","volume":"60","author":"MA del Aguila","year":"2003","unstructured":"del Aguila MA, Longstreth WT Jr., McGuire V, Koepsell TD, van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60(5):813\u2013819. https:\/\/doi.org\/10.1212\/01.wnl.0000049472.47709.3b","journal-title":"Neurology"},{"issue":"4","key":"13614_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s00415-018-8735-9","volume":"265","author":"A Rosenbohm","year":"2018","unstructured":"Rosenbohm A, Liu M, Nagel G, Peter RS, Cui B, Li X et al (2018) Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany. J Neurol 265(4):774\u2013782. https:\/\/doi.org\/10.1007\/s00415-018-8735-9","journal-title":"J Neurol"},{"issue":"9","key":"13614_CR20","doi-asserted-by":"publisher","first-page":"e012054","DOI":"10.1136\/bmjopen-2016-012054","volume":"6","author":"P Talman","year":"2016","unstructured":"Talman P, Duong T, Vucic S, Mathers S, Venkatesh S, Henderson R et al (2016) Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis\/motor neuron disease: Australian National Motor Neuron Disease observational cohort. BMJ Open 6(9):e012054. https:\/\/doi.org\/10.1136\/bmjopen-2016-012054","journal-title":"BMJ Open"},{"issue":"1-2","key":"13614_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/21678421.2017.1386688","volume":"19","author":"R Walhout","year":"2018","unstructured":"Walhout R, Verstraete E, van den Heuvel MP, Veldink JH, van den Berg LH (2018) Patterns of symptom development in patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 19(1\u20132):21\u201328. https:\/\/doi.org\/10.1080\/21678421.2017.1386688","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"10","key":"13614_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/ene.12474","volume":"21","author":"B Marin","year":"2014","unstructured":"Marin B, Hamidou B, Couratier P, Nicol M, Delzor A, Raymondeau M et al (2014) Population based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe\u2014the French register of ALS in Limousin (FRALim register). Eur J Neurol 21(10):1292\u20131300. https:\/\/doi.org\/10.1111\/ene.12474","journal-title":"Eur J Neurol"},{"issue":"7","key":"13614_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","volume":"82","author":"A Chio","year":"2011","unstructured":"Chio A, Calvo A, Moglia C, Mazzini L, Mora G, group Ps (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82(7):740\u2013746. https:\/\/doi.org\/10.1136\/jnnp.2010.235952","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"13614_CR24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","volume":"65","author":"GM Ringholz","year":"2005","unstructured":"Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65(4):586\u2013590. https:\/\/doi.org\/10.1212\/01.wnl.0000172911.39167.b6","journal-title":"Neurology"},{"issue":"1","key":"13614_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jnnp-2011-300188","volume":"83","author":"J Phukan","year":"2012","unstructured":"Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102\u2013108. https:\/\/doi.org\/10.1136\/jnnp-2011-300188","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"13614_CR26","doi-asserted-by":"publisher","first-page":"e87163","DOI":"10.1371\/journal.pone.0087163","volume":"9","author":"SI Oh","year":"2014","unstructured":"Oh SI, Park A, Kim HJ, Oh KW, Choi H, Kwon MJ et al (2014) Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations. PLoS ONE 9(2):e87163. https:\/\/doi.org\/10.1371\/journal.pone.0087163","journal-title":"PLoS ONE"},{"issue":"2","key":"13614_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jnnp-2013-307223","volume":"86","author":"A Montuschi","year":"2015","unstructured":"Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168\u2013173. https:\/\/doi.org\/10.1136\/jnnp-2013-307223","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13614_CR28","doi-asserted-by":"publisher","first-page":"103732","DOI":"10.1016\/j.ebiom.2021.103732","volume":"74","author":"WM Su","year":"2021","unstructured":"Su WM, Cheng YF, Jiang Z, Duan QQ, Yang TM, Shang HF et al (2021) Predictors of survival in patients with amyotrophic lateral sclerosis: a large meta-analysis. EBioMedicine 74:103732. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103732","journal-title":"EBioMedicine"},{"issue":"5","key":"13614_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"HJ Westeneng","year":"2018","unstructured":"Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A et al (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17(5):423\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(18)30089-9","journal-title":"Lancet Neurol"},{"issue":"7","key":"13614_CR30","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(15)00104-0","volume":"14","author":"ProGas Study G","year":"2015","unstructured":"ProGas Study G (2015) Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol 14(7):702\u2013709. https:\/\/doi.org\/10.1016\/S1474-4422(15)00104-0","journal-title":"Lancet Neurol"},{"issue":"3","key":"13614_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/jnnp-2014-310055","volume":"87","author":"DJ Berlowitz","year":"2016","unstructured":"Berlowitz DJ, Howard ME, Fiore JF Jr, Vander Hoorn S, O\u2019Donoghue FJ, Westlake J et al (2016) Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis\/motor neurone disease in a clinical cohort. J Neurol Neurosurg Psychiatry 87(3):280\u2013286. https:\/\/doi.org\/10.1136\/jnnp-2014-310055","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"13614_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/JND-221658","volume":"10","author":"M Sarasate","year":"2023","unstructured":"Sarasate M, Gonzalez N, Cordoba-Izquierdo A, Prats E, Gonzalez-Moro JMR, Marti S et al (2023) Impact of early non-invasive ventilation in amyotrophic lateral sclerosis: a multicenter randomized controlled trial. J Neuromuscul Dis 10(4):627\u2013637. https:\/\/doi.org\/10.3233\/JND-221658","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"13614_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","volume":"5","author":"SC Bourke","year":"2006","unstructured":"Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140\u2013147. https:\/\/doi.org\/10.1016\/S1474-4422(05)70326-4","journal-title":"Lancet Neurol"},{"issue":"3-4","key":"13614_CR34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/21678421.2024.2304058","volume":"25","author":"F Hobin","year":"2024","unstructured":"Hobin F, De Vocht J, Lamaire N, Beyens H, Ombelet F, Van Damme P (2024) Specialized multidisciplinary care improves ALS survival in Belgium: a population-based retrospective study. Amyotroph Lateral Scler Frontotemporal Degener 25(3\u20134):282\u2013289. https:\/\/doi.org\/10.1080\/21678421.2024.2304058","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"13614_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000369813","volume":"44","author":"H Cetin","year":"2015","unstructured":"Cetin H, Rath J, Fuzi J, Reichardt B, Fulop G, Koppi S et al (2015) Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course. Neuroepidemiology 44(1):6\u201315. https:\/\/doi.org\/10.1159\/000369813","journal-title":"Neuroepidemiology"},{"issue":"3","key":"13614_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1468-1331.2006.01575.x","volume":"14","author":"S Zoccolella","year":"2007","unstructured":"Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V et al (2007) Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Eur J Neurol 14(3):262\u2013268. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01575.x","journal-title":"Eur J Neurol"},{"issue":"4","key":"13614_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00415-003-1026-z","volume":"250","author":"BJ Traynor","year":"2003","unstructured":"Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O (2003) An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000. J Neurol 250(4):473\u2013479. https:\/\/doi.org\/10.1007\/s00415-003-1026-z","journal-title":"J Neurol"},{"issue":"1","key":"13614_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2188\/jea.je20120119","volume":"23","author":"CT Lee","year":"2013","unstructured":"Lee CT, Chiu YW, Wang KC, Hwang CS, Lin KH, Lee IT et al (2013) Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan. J Epidemiol 23(1):35\u201340. https:\/\/doi.org\/10.2188\/jea.je20120119","journal-title":"J Epidemiol"},{"issue":"sup1","key":"13614_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/21678421.2025.2472889","volume":"26","author":"R Vasta","year":"2025","unstructured":"Vasta R, Ombelet F, Hobin F, Manera U, Ammar AC, Caravaca Puchades A et al (2025) Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS. Amyotroph Lateral Scler Frontotemporal Degener 26(sup1):50\u201360. https:\/\/doi.org\/10.1080\/21678421.2025.2472889","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"13614_CR40","doi-asserted-by":"publisher","first-page":"e16379","DOI":"10.1111\/ene.16379","volume":"31","author":"T Meyer","year":"2024","unstructured":"Meyer T, Dreger M, Grehl T, Weyen U, Kettemann D, Weydt P et al (2024) Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: a longitudinal, multicenter study. Eur J Neurol 31(9):e16379. https:\/\/doi.org\/10.1111\/ene.16379","journal-title":"Eur J Neurol"},{"issue":"1","key":"13614_CR41","doi-asserted-by":"publisher","first-page":"fcac029","DOI":"10.1093\/braincomms\/fcac029","volume":"4","author":"AG Thompson","year":"2022","unstructured":"Thompson AG, Gray E, Verber N, Bobeva Y, Lombardi V, Shepheard SR et al (2022) Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain. Brain Commun 4(1):fcac029. https:\/\/doi.org\/10.1093\/braincomms\/fcac029","journal-title":"Brain Commun"},{"key":"13614_CR42","doi-asserted-by":"publisher","first-page":"651651","DOI":"10.3389\/fnins.2021.651651","volume":"15","author":"M Dreger","year":"2021","unstructured":"Dreger M, Steinbach R, Gaur N, Metzner K, Stubendorff B, Witte OW et al (2021) Cerebrospinal fluid neurofilament light chain (NfL) predicts disease aggressiveness in amyotrophic lateral sclerosis: an application of the D50 disease progression model. Front Neurosci 15:651651. https:\/\/doi.org\/10.3389\/fnins.2021.651651","journal-title":"Front Neurosci"},{"issue":"2","key":"13614_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ene.14063","volume":"27","author":"E Thouvenot","year":"2020","unstructured":"Thouvenot E, Demattei C, Lehmann S, Maceski-Maleska A, Hirtz C, Juntas-Morales R et al (2020) Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis. Eur J Neurol 27(2):251\u2013257. https:\/\/doi.org\/10.1111\/ene.14063","journal-title":"Eur J Neurol"},{"issue":"1","key":"13614_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia R, Chio A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17(1):94\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(17)30401-5","journal-title":"Lancet Neurol"},{"issue":"5","key":"13614_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chio A, Savelieff MG, Kiernan MC et al (2022) Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol 21(5):465\u2013479. https:\/\/doi.org\/10.1016\/S1474-4422(21)00414-2","journal-title":"Lancet Neurol"},{"issue":"7","key":"13614_CR46","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","volume":"88","author":"ZY Zou","year":"2017","unstructured":"Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP (2017) Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88(7):540\u2013549. https:\/\/doi.org\/10.1136\/jnnp-2016-315018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"13614_CR47","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","volume":"76","author":"M Ryan","year":"2019","unstructured":"Ryan M, Heverin M, McLaughlin RL, Hardiman O (2019) Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol 76(11):1367\u20131374. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2044","journal-title":"JAMA Neurol"},{"issue":"3","key":"13614_CR48","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1212\/NXG.0000000000000239","volume":"4","author":"M Ryan","year":"2018","unstructured":"Ryan M, Heverin M, Doherty MA, Davis N, Corr EM, Vajda A et al (2018) Determining the incidence of familiality in ALS: a study of temporal trends in Ireland from 1994 to 2016. Neurol Genet 4(3):e239. https:\/\/doi.org\/10.1212\/NXG.0000000000000239","journal-title":"Neurol Genet"},{"issue":"8","key":"13614_CR49","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1111\/ene.15855","volume":"30","author":"J Scaber","year":"2023","unstructured":"Scaber J, Thompson AG, Farrimond L, Feneberg E, Proudfoot M, Ossher L et al (2023) Advantages of routine next-generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic. Eur J Neurol 30(8):2240\u20132249. https:\/\/doi.org\/10.1111\/ene.15855","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13614-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:58:08Z","timestamp":1773665888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13614-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13614"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13614-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the ethics committee of the Medical University of Vienna (EK No. 1409\/2021) and conducted in accordance with the Declaration of Helsinki and all relevant guidelines. The requirement to obtain patient consent was waived for this retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and patient consent"}}],"article-number":"74"}}